Looking forward to outstanding candidates to apply for postdoc and research associate positions in our vibrant Biomaterials for Translational Research lab. Please see the job description and application info in this post.
One Postdoctoral Fellow and one Research Associate positions are available immediately in Dr. Loweโs Biomaterials for Translational Research Laboratory at UMD. Candidates with strong polymer and organic synthesis and mass spectroscopy background are preferred.
๐We proudly announce that we will grant $4 Million in #funding to advance #stemcell#research in Maryland. Recipients include 12 scientists at @JohnsHopkins, @UMBaltimore, @UMBC, & @UofMaryland.
ย
See the list of awardees in our press release here ๐ https://t.co/f7pwXVsZF2
Itโs my pleasure to congratulate our colleague and friend Dr. Laurie Locascio. Weโre grateful for her leadership while she served as VP for the University of Maryland Joint Research Enterprise. https://t.co/6RJuu7ssZD
A terps win in the Bronx! We had a blast cheering on @terpsfootball all season long, but especially at the @pinstripebowl today! We had a great time in New York City and we canโt wait to show you what weโve got in store for next year!
#PinstripeBowlChamps#msom#goterps
.@UMSOD_Dentistry ran a wonderful cover story to highlight Dr. Tao Lowe's work on the design of therapeutic strategies for the treatment of cancers and the regeneration of bone, cartilage, & other tissues: https://t.co/tgAvXrSKsx Dr. Lowe is a joint professor with BIOE & UMSOD.
Join us in congratulating our new AAPS Fellows!
Tao Lowe, Ph.D., is an international expert in pharmaceutical sciences, especially in biomaterials, drug delivery, nanotechnology, transport across biological barriers, and regenerative medicine.
https://t.co/vqeYGekPYC
Super excited that Graybug Vision, a company I started with @JohnsHopkins colleagues, went public today. Graybug will raise about $90-100million to continue development of drugs for ocular diseases that cause blindness (including #AMD and #glaucoma).
https://t.co/DbJaLU9PUm